Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Haploidentical transplantation for hematologic malignancies: where do we stand?

Hematology. American Society of Hematology. Education Program - 1 Jan 2012

Fuchs Ephraim J

Abstract excerpt

The fundamental obstacle to the successful application of partially HLA-mismatched related donor, or HLA-haploidentical stem cell transplantation, is the strength of the host and donor T-cell response to allogeneic HLA molecules, which results in increased incidences of graft failure, GVHD, and nonrelapse mortality. The holy grail of haplo-SCT is to mitigate host-versus-graft and graft-versus-host responses while...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclophosphamide
Share to Hematologic Neoplasms
Share to Histocompatibility

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immune System

Share to Stem Cell Transplantation

Share to T-Lymphocytes, Regulatory

Share to Tissue Donors

Share to Transplantation Conditioning

Source

Open in PubMed Open full text

Identifiers

PMID: 23233586
DOI: 10.1182/asheducation-2012.1.230
PMCID: PMC3657706

Genes

SCT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Haploidentical transplantation for hematologic malignancies: where do we stand?PMID 23233586Read ↗

Haploidentical hematopoietic transplantation: current status and future perspectivesSemantic proximity Read ↗

Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translationSemantic proximity Read ↗

Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and ControversiesSemantic proximity Read ↗

Hematopoietic stem cell transplants from unrelated donorsSemantic proximity Read ↗

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell TransplantSemantic proximity Read ↗

Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantationSemantic proximity Read ↗

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemiaSemantic proximity Read ↗

Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical VariablesSemantic proximity Read ↗

Human leucocyte antigen diversity: A biological gift to escape infections, no longer a barrier for haploidentical Hemopoietic Stem Cell Transplantation.Semantic proximity Read ↗

The history of haploidentical stem cell transplantation: a trip from the bench to the bedsideSemantic proximity Read ↗

Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A PerspectiveSemantic proximity Read ↗

How to select the best available related or unrelated donor of hematopoietic stem cells?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.